Excelsior Medical Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Ming-Cheng Chang
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 5.9yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 10.3yrs |
Recent management updates
Recent updates
Excelsior Medical's (TWSE:4104) Strong Earnings Are Of Good Quality
Nov 20
There's Been No Shortage Of Growth Recently For Excelsior Medical's (TPE:4104) Returns On Capital
Apr 22A Look At The Intrinsic Value Of Excelsior Medical Co., Ltd. (TPE:4104)
Apr 07What To Know Before Buying Excelsior Medical Co., Ltd. (TPE:4104) For Its Dividend
Feb 25Excelsior Medical (TPE:4104) Could Easily Take On More Debt
Feb 07
Returns On Capital - An Important Metric For Excelsior Medical (TPE:4104)
Jan 22Excelsior Medical (TPE:4104) Has Compensated Shareholders With A Respectable 46% Return On Their Investment
Jan 07Excelsior Medical Co., Ltd. (TPE:4104) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Dec 23Does Excelsior Medical's (TPE:4104) Statutory Profit Adequately Reflect Its Underlying Profit?
Dec 08Does Excelsior Medical Co., Ltd. (TPE:4104) Have A Place In Your Dividend Portfolio?
Nov 23CEO
Ming-Cheng Chang
5.9yrs
Tenure
Mr. Ming-Cheng Chang serves as General Manager at Excelsior Medical Co., Ltd. since January 01, 2019 and serves as its Director since June 21, 2022. He is a Director of Excelsior Renal Service Co., Ltd.(H...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 2.5yrs | no data | no data | |
| Chairman | 23.7yrs | no data | 0.33% NT$ 46.9m | |
| Supervisor | no data | no data | no data | |
| Independent Director | 12.5yrs | no data | no data | |
| Representative Director | 23.7yrs | no data | 0.39% NT$ 54.8m | |
| Independent Director | 2.5yrs | no data | no data | |
| Independent Director | 8.5yrs | no data | no data | |
| Director | 11.5yrs | no data | no data | |
| Director | 8.5yrs | no data | 0.071% NT$ 9.9m | |
| Vice Chairman | 10.3yrs | no data | 0.011% NT$ 1.5m |
10.3yrs
Average Tenure
Experienced Board: 4104's board of directors are seasoned and experienced ( 10.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 11:39 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Excelsior Medical Co., Ltd. is covered by 10 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jenny Tsai | BNP Paribas Securities (Asia) |
| Pinghan Hsieh | Capital Securities Corporation |
| Albert Hsu | Daiwa Securities Co. Ltd. |